PharmGKB summary: citalopram pharmacokinetics pathway.

Article Details

Citation

Copy to clipboard

Sangkuhl K, Klein TE, Altman RB

PharmGKB summary: citalopram pharmacokinetics pathway.

Pharmacogenet Genomics. 2011 Nov;21(11):769-72. doi: 10.1097/FPC.0b013e328346063f.

PubMed ID

21546862 [ View in PubMed

]

Abstract

Not Available

DrugBank Data that Cites this Article

Drugs

Citalopram

Drug Targets

Drug	Target	Kind	Organism	Pharmacological Action	Actions
Citalopram	Sodium-dependent serotonin transporter	Protein	Humans	Yes	Inhibitor	Details

Drug Enzymes

Drug	Enzyme	Kind	Organism	Pharmacological Action	Actions
Citalopram	Aldehyde oxidase	Protein	Humans	No	Substrate	Details
Citalopram	Amine oxidase [flavin-containing] A	Protein	Humans	No	Substrate	Details
Citalopram	Amine oxidase [flavin-containing] B	Protein	Humans	No	Substrate	Details
Citalopram	Cytochrome P450 3A4	Protein	Humans	No	Substrate Inhibitor	Details
Escitalopram	Cytochrome P450 3A4	Protein	Humans	No	Substrate	Details

Drug Reactions

Reaction
Citalopram DB00215 Cytochrome P450 2C19 Cytochrome P450 3A4 desmethylcitalopram DBMET03704	Details
Citalopram DB00215 Amine oxidase [flavin-containing] A Amine oxidase [flavin-containing] B Citalopram propionic aldehyde DBMET03706	Details
Citalopram DB00215 Cytochrome P450 2D6 citalopram N-oxide DBMET03708	Details